Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13026
PUT
Equillium
EQ
$126M
| $52.5K | ﹤0.01% |
16,400
-14,800
| -47% | -$35.5K |
|
|
XRTX
13027
XORTX Therapeutics
XRTX
$3.31M
| $52.5K | ﹤0.01% |
+23,116
| New | +$55.2K |
|
|
NMG
13028
PUT
Nouveau Monde Graphite
NMG
$438M
| $52.4K | ﹤0.01% |
34,900
-6,000
| -15% | -$11.3K |
|
13029
PUT
iHeartMedia
IHRT
$407M
| $52.3K | ﹤0.01% |
12,200
-9,600
| -44% | -$42.6K |
|
13030
PUT
Playboy Inc
PLBY
$135M
| $52.3K | ﹤0.01% |
42,900
+27,800
| +184% | +$42.2K |
|
13031
CALL
Orchestra BioMed
OBIO
$371M
| $52.2K | ﹤0.01% |
+12,100
| New | +$49.5K |
|
|
CYAB
13032
Cyabra Inc
CYAB
$5.28M
| $52K | ﹤0.01% |
+132,755
| New | +$110K |
|
13033
PUT
Ovid Therapeutics
OVID
$535M
| $51.9K | ﹤0.01% |
19,300
-1,200
| -6% | -$3.1K |
|
|
ORIO
13034
Orion Digital Corp
ORIO
$24.8M
| $51.7K | ﹤0.01% |
+60,877
| New | +$58.6K |
|
13035
CALL
Lineage Cell Therapeutics
LCTX
$271M
| $51.6K | ﹤0.01% |
39,400
+4,100
| +12% | +$5.67K |
|
|
NA
13036
CALL
Nano Labs
NA
$51.3M
| $51.4K | ﹤0.01% |
+27,800
| New | +$63.9K |
|
|
TWAV
13037
TaoWeave Inc
TWAV
$4.69M
| $51.4K | ﹤0.01% |
+37,237
| New | +$59.7K |
|
|
SJT
13038
CALL
San Juan Basin Royalty Trust
SJT
$138M
| $51.4K | ﹤0.01% |
16,000
-27,800
| -63% | -$112K |
|
13039
Mobile Infrastructure Corp
BEEP
$116M
| $51.3K | ﹤0.01% |
37,170
+20,111
| +118% | +$39.9K |
|
13040
CBL International Ltd
BANL
$12.2M
| $51.2K | ﹤0.01% |
+11,407
| New | +$66.4K |
|
|
FOXX
13041
Foxx Development Holdings
FOXX
$17.5M
| $51.1K | ﹤0.01% |
15,630
-14,020
| -47% | -$61.2K |
|
13042
CALL
SelectQuote
SLQT
$88.3M
| $51K | ﹤0.01% |
60,600
+44,100
| +267% | +$40.1K |
|
13043
PUT
Rimini Street
RMNI
$421M
| $50.7K | ﹤0.01% |
11,900
-1,700
| -13% | -$6.45K |
|
13044
Silynxcom
SYNX
$5.52M
| $50.7K | ﹤0.01% |
+49,205
| New | +$56.8K |
|
|
BRNS
13045
DELISTED
Barinthus Biotherapeutics
BRNS
| $50.7K | ﹤0.01% |
76,754
-42,242
| -35% | -$27.5K |
|
13046
CALL
CS Disco
LAW
$274M
| $50.7K | ﹤0.01% |
13,400
+2,200
| +20% | +$8.53K |
|
|
PAAI
13047
CALL
Paradium.AI, Inc.
PAAI
$45.5M
| $50.5K | ﹤0.01% |
60,900
+46,000
| +309% | +$79.8K |
|
|
NAKA
13048
PUT
Nakamoto Inc
NAKA
$141M
| $50.5K | ﹤0.01% |
12,790
+9,662
| +309% | +$64.5K |
|
|
AACG
13049
ATA Creativity
AACG
$35.9M
| $50.5K | ﹤0.01% |
49,001
-10,964
| -18% | -$11.9K |
|
|
EARN
13050
PUT
Ellington Residential Mortgage REIT
EARN
$156M
| $50.4K | ﹤0.01% |
+11,400
| New | +$53.2K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.